IBDEI04N ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11164,1,3,0)
 ;;=3^DM Type 1 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,11164,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,11164,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,11165,0)
 ;;=E10.621^^48^517^6
 ;;^UTILITY(U,$J,358.3,11165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11165,1,3,0)
 ;;=3^DM Type 1 w/ Diab Foot Ulcer
 ;;^UTILITY(U,$J,358.3,11165,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,11165,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,11166,0)
 ;;=E10.622^^48^517^28
 ;;^UTILITY(U,$J,358.3,11166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11166,1,3,0)
 ;;=3^DM Type 1 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,11166,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,11166,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,11167,0)
 ;;=E10.51^^48^517^32
 ;;^UTILITY(U,$J,358.3,11167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11167,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,11167,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,11167,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,11168,0)
 ;;=E10.52^^48^517^31
 ;;^UTILITY(U,$J,358.3,11168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11168,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,11168,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,11168,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,11169,0)
 ;;=E11.00^^48^518^19
 ;;^UTILITY(U,$J,358.3,11169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11169,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
 ;;^UTILITY(U,$J,358.3,11169,1,4,0)
 ;;=4^E11.00
 ;;^UTILITY(U,$J,358.3,11169,2)
 ;;=^5002627
 ;;^UTILITY(U,$J,358.3,11170,0)
 ;;=E11.01^^48^518^18
 ;;^UTILITY(U,$J,358.3,11170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11170,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
 ;;^UTILITY(U,$J,358.3,11170,1,4,0)
 ;;=4^E11.01
 ;;^UTILITY(U,$J,358.3,11170,2)
 ;;=^5002628
 ;;^UTILITY(U,$J,358.3,11171,0)
 ;;=E11.21^^48^518^7
 ;;^UTILITY(U,$J,358.3,11171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11171,1,3,0)
 ;;=3^DM Type 2 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,11171,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,11171,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,11172,0)
 ;;=E11.22^^48^518^3
 ;;^UTILITY(U,$J,358.3,11172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11172,1,3,0)
 ;;=3^DM Type 2 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,11172,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,11172,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,11173,0)
 ;;=E11.39^^48^518^28
 ;;^UTILITY(U,$J,358.3,11173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11173,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,11173,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,11173,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,11174,0)
 ;;=E11.41^^48^518^6
 ;;^UTILITY(U,$J,358.3,11174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11174,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,11174,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,11174,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,11175,0)
 ;;=E11.42^^48^518^13
 ;;^UTILITY(U,$J,358.3,11175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11175,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,11175,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,11175,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,11176,0)
 ;;=E11.43^^48^518^2
 ;;^UTILITY(U,$J,358.3,11176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11176,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,11176,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,11176,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,11177,0)
 ;;=E11.44^^48^518^1
 ;;^UTILITY(U,$J,358.3,11177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11177,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,11177,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,11177,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,11178,0)
 ;;=E11.49^^48^518^8
 ;;^UTILITY(U,$J,358.3,11178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11178,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,11178,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,11178,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,11179,0)
 ;;=E11.59^^48^518^25
 ;;^UTILITY(U,$J,358.3,11179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11179,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,11179,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,11179,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,11180,0)
 ;;=E11.610^^48^518^9
 ;;^UTILITY(U,$J,358.3,11180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11180,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,11180,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,11180,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,11181,0)
 ;;=E11.618^^48^518^26
 ;;^UTILITY(U,$J,358.3,11181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11181,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,11181,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,11181,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,11182,0)
 ;;=E11.621^^48^518^16
 ;;^UTILITY(U,$J,358.3,11182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11182,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,11182,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,11182,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,11183,0)
 ;;=E11.622^^48^518^31
 ;;^UTILITY(U,$J,358.3,11183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11183,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,11183,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,11183,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,11184,0)
 ;;=E11.628^^48^518^30
 ;;^UTILITY(U,$J,358.3,11184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11184,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,11184,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,11184,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,11185,0)
 ;;=E11.630^^48^518^33
 ;;^UTILITY(U,$J,358.3,11185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11185,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,11185,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,11185,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,11186,0)
 ;;=E11.638^^48^518^29
 ;;^UTILITY(U,$J,358.3,11186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11186,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,11186,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,11186,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,11187,0)
 ;;=E11.641^^48^518^20
 ;;^UTILITY(U,$J,358.3,11187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11187,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,11187,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,11187,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,11188,0)
 ;;=E11.649^^48^518^21
 ;;^UTILITY(U,$J,358.3,11188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11188,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,11188,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,11188,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,11189,0)
 ;;=E11.65^^48^518^17
 ;;^UTILITY(U,$J,358.3,11189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11189,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,11189,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,11189,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,11190,0)
 ;;=E11.69^^48^518^32
 ;;^UTILITY(U,$J,358.3,11190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11190,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,11190,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,11190,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,11191,0)
 ;;=E11.8^^48^518^34
 ;;^UTILITY(U,$J,358.3,11191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11191,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,11191,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,11191,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,11192,0)
 ;;=E11.9^^48^518^35
 ;;^UTILITY(U,$J,358.3,11192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11192,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,11192,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,11192,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,11193,0)
 ;;=E11.29^^48^518^27
 ;;^UTILITY(U,$J,358.3,11193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11193,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,11193,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,11193,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,11194,0)
 ;;=E11.311^^48^518^14
 ;;^UTILITY(U,$J,358.3,11194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11194,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,11194,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,11194,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,11195,0)
 ;;=E11.319^^48^518^15
 ;;^UTILITY(U,$J,358.3,11195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11195,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,11195,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,11195,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,11196,0)
 ;;=E11.3211^^48^518^22
 ;;^UTILITY(U,$J,358.3,11196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11196,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,11196,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,11196,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,11197,0)
 ;;=E11.3212^^48^518^23
 ;;^UTILITY(U,$J,358.3,11197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11197,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,11197,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,11197,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,11198,0)
 ;;=E11.3213^^48^518^24
 ;;^UTILITY(U,$J,358.3,11198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11198,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,11198,1,4,0)
 ;;=4^E11.3213
 ;;^UTILITY(U,$J,358.3,11198,2)
 ;;=^5138333
 ;;^UTILITY(U,$J,358.3,11199,0)
 ;;=E11.40^^48^518^10
 ;;^UTILITY(U,$J,358.3,11199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11199,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,11199,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,11199,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,11200,0)
 ;;=E11.51^^48^518^12
 ;;^UTILITY(U,$J,358.3,11200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11200,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,11200,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,11200,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,11201,0)
 ;;=E11.52^^48^518^11
 ;;^UTILITY(U,$J,358.3,11201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11201,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,11201,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,11201,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,11202,0)
 ;;=E11.620^^48^518^5
 ;;^UTILITY(U,$J,358.3,11202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11202,1,3,0)
 ;;=3^DM Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,11202,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,11202,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,11203,0)
 ;;=E11.36^^48^518^4
 ;;^UTILITY(U,$J,358.3,11203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11203,1,3,0)
 ;;=3^DM Type 2 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,11203,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,11203,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,11204,0)
 ;;=I10.^^48^519^1
 ;;^UTILITY(U,$J,358.3,11204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11204,1,3,0)
 ;;=3^Essential/Primary Hypertension
 ;;^UTILITY(U,$J,358.3,11204,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,11204,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,11205,0)
 ;;=I11.0^^48^519^12
 ;;^UTILITY(U,$J,358.3,11205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11205,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,11205,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,11205,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,11206,0)
 ;;=I11.9^^48^519^13
 ;;^UTILITY(U,$J,358.3,11206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11206,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,11206,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,11206,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,11207,0)
 ;;=I12.0^^48^519^5
 ;;^UTILITY(U,$J,358.3,11207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11207,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
 ;;^UTILITY(U,$J,358.3,11207,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,11207,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,11208,0)
 ;;=I12.9^^48^519^4
 ;;^UTILITY(U,$J,358.3,11208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11208,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
 ;;^UTILITY(U,$J,358.3,11208,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,11208,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,11209,0)
 ;;=I13.0^^48^519^8
 ;;^UTILITY(U,$J,358.3,11209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11209,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,11209,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,11209,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,11210,0)
 ;;=I13.10^^48^519^10
 ;;^UTILITY(U,$J,358.3,11210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11210,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,11210,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,11210,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,11211,0)
 ;;=I13.11^^48^519^11
 ;;^UTILITY(U,$J,358.3,11211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11211,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,11211,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,11211,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,11212,0)
 ;;=I13.2^^48^519^9
 ;;^UTILITY(U,$J,358.3,11212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11212,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,11212,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,11212,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,11213,0)
 ;;=I15.0^^48^519^15
 ;;^UTILITY(U,$J,358.3,11213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11213,1,3,0)
 ;;=3^Renovascular Hypertension
 ;;^UTILITY(U,$J,358.3,11213,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,11213,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,11214,0)
 ;;=I15.1^^48^519^3
 ;;^UTILITY(U,$J,358.3,11214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11214,1,3,0)
 ;;=3^Hypertension Secondary to Oth Renal Disorders
 ;;^UTILITY(U,$J,358.3,11214,1,4,0)
 ;;=4^I15.1
 ;;^UTILITY(U,$J,358.3,11214,2)
 ;;=^5007072
 ;;^UTILITY(U,$J,358.3,11215,0)
 ;;=I15.2^^48^519^2
 ;;^UTILITY(U,$J,358.3,11215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11215,1,3,0)
 ;;=3^Hypertension Secondary to Endocrine Disorders
 ;;^UTILITY(U,$J,358.3,11215,1,4,0)
 ;;=4^I15.2
 ;;^UTILITY(U,$J,358.3,11215,2)
 ;;=^5007073
 ;;^UTILITY(U,$J,358.3,11216,0)
 ;;=I15.8^^48^519^16
 ;;^UTILITY(U,$J,358.3,11216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11216,1,3,0)
 ;;=3^Secondary Hypertension,Oth
 ;;^UTILITY(U,$J,358.3,11216,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,11216,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,11217,0)
 ;;=I15.9^^48^519^17
 ;;^UTILITY(U,$J,358.3,11217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11217,1,3,0)
 ;;=3^Secondary Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,11217,1,4,0)
 ;;=4^I15.9
 ;;^UTILITY(U,$J,358.3,11217,2)
 ;;=^5007075
 ;;^UTILITY(U,$J,358.3,11218,0)
 ;;=I16.0^^48^519^14
 ;;^UTILITY(U,$J,358.3,11218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11218,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,11218,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,11218,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,11219,0)
 ;;=I16.1^^48^519^7
 ;;^UTILITY(U,$J,358.3,11219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11219,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,11219,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,11219,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,11220,0)
 ;;=I16.9^^48^519^6
 ;;^UTILITY(U,$J,358.3,11220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11220,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,11220,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,11220,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,11221,0)
 ;;=A07.0^^48^520^5
 ;;^UTILITY(U,$J,358.3,11221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11221,1,3,0)
 ;;=3^Balantidiasis
 ;;^UTILITY(U,$J,358.3,11221,1,4,0)
 ;;=4^A07.0
 ;;^UTILITY(U,$J,358.3,11221,2)
 ;;=^12533
 ;;^UTILITY(U,$J,358.3,11222,0)
 ;;=A07.1^^48^520^9
 ;;^UTILITY(U,$J,358.3,11222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11222,1,3,0)
 ;;=3^Giardiasis [lambliasis]
 ;;^UTILITY(U,$J,358.3,11222,1,4,0)
 ;;=4^A07.1
 ;;^UTILITY(U,$J,358.3,11222,2)
 ;;=^5000049
 ;;^UTILITY(U,$J,358.3,11223,0)
 ;;=A07.2^^48^520^7
 ;;^UTILITY(U,$J,358.3,11223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11223,1,3,0)
 ;;=3^Cryptosporidiosis
 ;;^UTILITY(U,$J,358.3,11223,1,4,0)
 ;;=4^A07.2
 ;;^UTILITY(U,$J,358.3,11223,2)
 ;;=^29629
 ;;^UTILITY(U,$J,358.3,11224,0)
 ;;=A07.3^^48^520^12
 ;;^UTILITY(U,$J,358.3,11224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11224,1,3,0)
 ;;=3^Isosporiasis
 ;;^UTILITY(U,$J,358.3,11224,1,4,0)
 ;;=4^A07.3
 ;;^UTILITY(U,$J,358.3,11224,2)
 ;;=^5000050
 ;;^UTILITY(U,$J,358.3,11225,0)
 ;;=A07.4^^48^520^8
 ;;^UTILITY(U,$J,358.3,11225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11225,1,3,0)
 ;;=3^Cyclosporiasis
 ;;^UTILITY(U,$J,358.3,11225,1,4,0)
 ;;=4^A07.4
 ;;^UTILITY(U,$J,358.3,11225,2)
 ;;=^321973
 ;;^UTILITY(U,$J,358.3,11226,0)
 ;;=A07.8^^48^520^14
 ;;^UTILITY(U,$J,358.3,11226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11226,1,3,0)
 ;;=3^Protozoal Intestinal Diseases,Oth Spec
 ;;^UTILITY(U,$J,358.3,11226,1,4,0)
 ;;=4^A07.8
 ;;^UTILITY(U,$J,358.3,11226,2)
 ;;=^265972
 ;;^UTILITY(U,$J,358.3,11227,0)
 ;;=A07.9^^48^520^13
 ;;^UTILITY(U,$J,358.3,11227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11227,1,3,0)
 ;;=3^Protozoal Intestinal Disease,Unspec
 ;;^UTILITY(U,$J,358.3,11227,1,4,0)
 ;;=4^A07.9
 ;;^UTILITY(U,$J,358.3,11227,2)
 ;;=^5000051
 ;;^UTILITY(U,$J,358.3,11228,0)
 ;;=A08.0^^48^520^15
 ;;^UTILITY(U,$J,358.3,11228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11228,1,3,0)
 ;;=3^Rotaviral Enteritis
 ;;^UTILITY(U,$J,358.3,11228,1,4,0)
 ;;=4^A08.0
 ;;^UTILITY(U,$J,358.3,11228,2)
 ;;=^5000052
 ;;^UTILITY(U,$J,358.3,11229,0)
 ;;=A08.11^^48^520^1
 ;;^UTILITY(U,$J,358.3,11229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11229,1,3,0)
 ;;=3^Acute Gastroenteropathy d/t Norwalk Agent
 ;;^UTILITY(U,$J,358.3,11229,1,4,0)
 ;;=4^A08.11
 ;;^UTILITY(U,$J,358.3,11229,2)
 ;;=^5000053
 ;;^UTILITY(U,$J,358.3,11230,0)
 ;;=A08.19^^48^520^2
 ;;^UTILITY(U,$J,358.3,11230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11230,1,3,0)
 ;;=3^Acute Gastroenteropathy d/t Oth Small Round Viruses
 ;;^UTILITY(U,$J,358.3,11230,1,4,0)
 ;;=4^A08.19
 ;;^UTILITY(U,$J,358.3,11230,2)
 ;;=^5000054
 ;;^UTILITY(U,$J,358.3,11231,0)
 ;;=A08.2^^48^520^3
 ;;^UTILITY(U,$J,358.3,11231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11231,1,3,0)
 ;;=3^Adenoviral Enteritis
 ;;^UTILITY(U,$J,358.3,11231,1,4,0)
 ;;=4^A08.2
 ;;^UTILITY(U,$J,358.3,11231,2)
 ;;=^5000055
 ;;^UTILITY(U,$J,358.3,11232,0)
 ;;=A08.31^^48^520^6
 ;;^UTILITY(U,$J,358.3,11232,1,0)
 ;;=^358.31IA^4^2
